The pathogenic fungus Candida glabrata is relatively resistant to azole antifungals, which target lanosterol 14a-demethylase (Erg11p) in the ergosterol biosynthesis pathway. Our study revealed that C. glabrata exhibits increased azole susceptibility under low-iron conditions. To investigate the molecular basis of this phenomenon, we generated a strain lacking the heme (iron protoporphyrin IX)-binding protein Dap1 in C. glabrata. The Ddap1 mutant displayed growth defects under iron-limited conditions, decreased azole tolerance, decreased production of ergosterol, and increased accumulation of 14a-methylated sterols lanosterol and squalene. All the Ddap1 phenotypes were complemented by wild-type DAP1, but not by DAP1
Introduction
Azole antifungals inhibit ergosterol biosynthesis by targeting the cytochrome P450 enzyme, lanosterol 14a-demethylase, encoded by ERG11 (Odds et al., 2003) . Candida glabrata is the second most common cause of candidemia after Candida albicans and is most notable for its reduced susceptibility to azole antifungals such as fluconazole (Pfaller & Diekema, 2007; Pfaller, 2012) . As only limited antifungal agents are available in clinical settings, there is an urgent need to develop a therapeutic strategy effective for a broad range of fungal pathogens, including C. glabrata.
Iron is an essential element for all living organisms, serving as a co-factor for a variety of proteins. Host-iron availability and its intracellular metabolism are crucial for the virulence of pathogens (Sutak et al., 2008; Almeida et al., 2009 ). In addition, previous studies of C. albicans, Cryptococcus neoformans, and Aspergillus fumigatus have demonstrated that these pathogenic fungi display increased fluconazole susceptibilities under iron-limited conditions (Prasad et al., 2006; Zarember et al., 2009; Kim et al., 2012) . Iron depletion leads to down-regulation of ERG11 and a partial defect in ergosterol biosynthesis, thereby enhancing membrane fluidity and passive drug diffusion in C. albicans cells (Prasad et al., 2006) . The syntheses of heme (iron protoporphyrin IX) and ergosterol are closely related, because they share the same upstream precursors (Weinstein et al., 1986) . However, the molecular base of the link between iron metabolism and azole resistance are poorly understood in pathogenic fungi.
In the model yeast Saccharomyces cerevisiae, the hemebinding protein damage-resistance protein 1 (Dap1), which is related to cytochrome b5 (Mifsud & Bateman, 2002) , is required for cell growth under low-iron conditions (Craven et al., 2007) . A genome-wide analysis has revealed that some members of the iron regulon involved in siderophore transport and high-affinity iron transport systems are down-regulated in the Ddap1 mutant, indicating a specific role for Dap1 in iron metabolism (Jo et al., 2009) . Intriguingly, Dap1 is also involved in ergosterol biosynthesis through the activation of Erg11 in S. cerevisiae (Hand et al., 2003; Mallory et al., 2005; Craven et al., 2007) . It has also been reported that Dap1 directly binds to and positively regulates Erg11 in Schizosaccharomyces pombe (Hughes et al., 2007) .
In the present study, our objectives were to evaluate the effects of iron starvation on azole susceptibility in C. glabrata and to explore molecular mechanisms linking iron homeostasis with azole resistance. To this end, we have characterized the functions of the Dap1 ortholog in C. glabrata.
Materials and methods

Media, drugs, and culture conditions
Candida glabrata cells were routinely propagated at 30°C in synthetic defined (SD) medium, synthetic complete (SC) medium, or SC medium lacking tryptophan (SCtrp) (Kaiser et al., 1994) , unless otherwise noted. Irondepleted conditions were induced by adding the bacterial siderophore desferrioxamine (DFO; EMD Chemicals, San Diego, CA) or the Fe 2+ chelator bathophenanthroline disulfonate (BPS; MP Biomedicals, Solon, OH) into media. Fluconazole was purchased from Sigma (St. Louis, MO), and voriconazole was kindly provided by Pfizer (New York, NY). Voriconazole was dissolved in dimethyl sulfoxide (DMSO), and other compounds were dissolved in distilled water. DMSO alone did not interfere with cell growth at the final concentrations used in this study. The AnaeroPack system (Mitsubishi Gas Chemical Company Inc., Tokyo, Japan) was used for cultures under conditions of low oxygen tension.
Strain and plasmid construction
Strains, primers, and plasmids used in this study are listed in Tables 1, 2 , and 3, respectively. A C. glabrata DAP1 deletion construct was made using a one-step PCR-based technique, as described previously (Miyazaki et al., 2010a, b) . Briefly, a 1-kb DNA fragment containing C. glabrata HIS3 was amplified from pBSK-HIS (Miyazaki et al., 2010a, b) using primers tagged with 100-bp sequences homologous to the flanking regions of the DAP1 open reading frame (ORF). Candida glabrata strain KUE200 (Ueno et al., 2007) was transformed with the deletion construct according to a lithium acetate protocol , and the resulting transformants (Ddap1 mutants) were selected by histidine prototrophy. PCR and Southern blotting were performed to verify that the desired homologous recombination occurred at the target locus without ectopic integration of the deletion construct.
To generate complementation plasmids, C. glabrata genes were amplified from the genomic DNA of CBS138 (Dujon et al., 2004) . A 1.5-kb PCR fragment containing the 1-kb upstream region and ORF of C. glabrata DAP1 was amplified with primers CgDAP1-F(-989)-Bam and CgDAP1-R(459)-Xho, digested with BamHI and XhoI, and then inserted into the BamHI-SalI site of pCgACT to generate pCgACT-DAP1. A Dap1-D91G mutation was introduced in pCgACT-DAP1 using the KOD-PlusMutagenesis kit (Toyobo, Osaka, Japan) and mutagenic primers CgDAP1-mut-F1 and CgDAP1-mut-R1, forming pCgACT-DAP1 D91G . A 0.5-kb PCR fragment containing the C. glabrata DAP1 ORF without stop codon was amplified from pCgACT-DAP1 with primers CgDAP1-F1-Bam and CgDAP1-R456-HdIII, and then digested with BamHI and HindIII. A 0.7-kb PCR fragment containing yEGFP1 were obtained from pYGFP1 with primers EGFP1-F-HdIII and EGFP1-R-Xho, and then digested with HindIII and XhoI. These DNA fragments were concurrently inserted into the BamHI-SalI site of pCg-ACT-P to generate pCgACTP-DAP1-GFP. A 1.8-kb PCR fragment containing C. glabrata ERG11 was amplified with primers CgERG11-F1-Xho and CgERG11-R(190)-Xho, digested with XhoI, and then inserted into the SalI site of pCgACT-P to generate pCgACTP-ERG11. All of the plasmids constructed using PCR products were verified by sequencing before use.
Drug susceptibility assays
Broth microdilution tests were performed essentially according to CLSI M27-A3 protocols using SD medium in a checkerboard format. The fractional inhibitory concentration (FIC) index was calculated by the following formula based on the MICs of 2 drugs used alone as well as in combination: FIC index = (MIC 80 of azole in combination/MIC 80 of azole alone) + (MIC 80 of DFO in combination/MIC 80 of DFO alone). Drug interaction was classified as synergistic if its FIC index was 0.5, as described previously (Odds, 2003; Johnson et al., 2004) . Spot dilution tests were performed as described previously (Miyazaki et al., 2010a, b) . Logarithmic-phase cultures of each C. glabrata strain were adjusted to 2 9 10 7 cells per mL, and then 5 lL of serial 10-fold dilutions were spotted onto SC-trp plates containing each compound at the indicated concentrations. Plates were photographed after 48 h of incubation at 30°C. All sensitivity tests were performed on at least three separate occasions to ensure reproducibility.
Sterol analysis
Candida glabrata cell pellets (10 OD 600 units) were harvested, washed twice with 0.5% Tween 80, and then rewashed with and resuspended in 1% NaCl. Ten micrograms of sitosterol, dissolved in chloroform, was added as an internal control. Total lipids were extracted using the Bligh-Dyer method (Bligh & Dyer, 1959) and saponified Table 2 . Primers used in this study Kitada et al. (1996) pCgACT-P pCgACT containing the S. cerevisiae PGK1 promoter, polylinker, and C. glabrata HIS3 3′UTR Miyazaki et al. pCgACT containing a C. glabrata DAP1 variant, in which the residues D91 within the heme-binding domain was mutated to glycine This study pCgACTP-DAP1-GFP pCgACT-P containing the C. glabrata DAP1-yEGFP1 fusion gene This study pCgACTP-ERG11 pCgACT-P containing C. glabrata ERG11 This study with 0.4 M methanolic KOH (Lewis et al., 1987) . The extracted lipids were dried under N 2 gas and dissolved in 100 lL of chloroform/methanol (2 : 1). Ten microliters of the aliquot were injected onto a C-18 column (COS-MOSIL 5C18-AR-II 4.6 9 150 mm) and analyzed by reverse-phase high-performance liquid chromatography (HPLC) using the Alliance HPLC system with the Waters 2695 separation module and 2489 UV/visible detector (Waters Corporation, Milford, MA). The mobile phase consisted of 99.5% methanol with 5 mM CH 3 COONH 4 . Elution of compounds was automatically monitored by absorption at 210nm. For sterol quantification, standard curves were prepared using the commercially available sterols (ergosterol, lanosterol, sitosterol, and squalene; Sigma). The dynamic range of each sterol standard curve was 10 ng-6 lg per injection. All experiments were performed on 2 independent occasions to ensure the reproducibility of the results.
Fluorescence microscopy
Vacuolar staining with FM4-64 was carried out as described previously (Vida & Emr, 1995) 
Results and discussion
Candida glabrata displays increased azole susceptibility under iron-limited conditions
To evaluate the effects of iron starvation on azole susceptibility of the C. glabrata wild-type strain, we conducted checkerboard assays using twofold serial dilutions of DFO, fluconazole, and voriconazole. Because C. glabrata is unable to utilize the bacterial siderophore DFO, the addition of this substance to growth medium induces an iron-depleted condition for this fungus (Nevitt & Thiele, 2011) . Increased fluconazole and voriconazole susceptibilities were observed in the presence of DFO even in C. glabrata (Fig. 1) . FIC indexes of the combination of fluconazole and DFO and the combination of voriconazole and DFO were 0.5 and 0.375, respectively, indicating synergistic effects of these azoles and DFO against C. glabrata. Fig. 1 . Azole susceptibility of Candida glabrata wild-type strain under iron-depleted conditions. MICs were determined by a broth microdilution test in a checkerboard format essentially according to CLSI M27-A3 guidelines. Cells were grown in SD medium in the presence of the bacterial siderophore desferrioxamine and fluconazole (left panel) or voriconazole (right panel) at the indicated concentrations. Plates were incubated at 35°C for 48 h and absorbance at 600 nm (OD 600 ) was measured.
Identification of the DAP1 ortholog in C. glabrata
To determine the molecular basis of the relationship between iron homeostasis and azole resistance in C. glabrata, we addressed functional characterization of the C. (Fig. 2) . Based on the significant sequence homology, we named the corresponding C. glabrata gene DAP1.
Candida glabrata cells require Dap1 for growth under iron-limited conditions and in the presence of azole antifungals
To investigate Dap1 functions, a Ddap1 mutant lacking the entire DAP1 ORF was constructed and then transformed with an empty vector and a plasmid containing a C. glabrata gene of interest. In S. cerevisiae Dap1, mutation of residue D91 in the heme-binding domain to glycine (D91G) abolished its heme-binding activity (Mallory et al., 2005) . As this residue is highly conserved among fungi (indicated by an asterisk in Fig. 2) , we introduced the corresponding mutation in C. glabrata DAP1 to generate a DAP1 D91G variant. The Ddap1 mutant displayed growth defects on iron-deficient media containing 100 lM DFO or 25 lM BPS; moreover, these phenotypes could be complemented by wild-type DAP1, but not by DAP1 D91G (Fig. 3a) . As expected, supplementation of the media with 1 mM ferric chloride (FeCl 3 ) completely rescued growth of all the strains tested. These results suggested that Dap1 plays a role in iron metabolism and that its heme-binding activity is necessary for this process in C. glabrata, consistent with previous findings in S. cerevisiae (Craven et al., 2007) . On the other hand, the Ddap1 and DAP1 D91G mutants exhibited increased azole susceptibility that was not fully rescued by addition of 1 mM FeCl 3 into the media (Fig. 3a) , indicating that both iron and Dap1 are required for azole resistance in C. glabrata.
Dap1 is involved in ergosterol biosynthesis via Erg11 in C. glabrata
The impaired growth of the Ddap1 and DAP1 D91G mutants in the presence of azole antifungals was completely rescued by supplementation of the media with exogenous ergosterol (Fig. 3b) . In contrast to the results with fluconazole and voriconazole, the loss of DAP1 did not affect susceptibility to fenpropimorph (Fig. 3a) , which targets C-8 sterol isomerase (Erg2p) and C-14 sterol reductase (Erg24p) (Marcireau et al., 1990; Jia et al., 2002) . These results suggest a possible involvement of Dap1 in ergosterol biosynthesis via Erg11. Thus, we next (a) (b) Fig. 3 . Spot dilution assay. (a) Serial 10-fold dilutions of Candida glabrata log-phase cells were spotted onto SC-trp plates containing each compound at the indicated concentrations. Plates were incubated at 30°C for 48 h. C. glabrata strains: Wild-type control, TG12; Ddap1 + vector, TG252; Ddap1 + DAP1, TG253; Ddap1 + DAP1 D91G , TG254; and Ddap1 + DAP1-EGFP1, TG255. FeCl 3 , ferric chloride; DFO, desferrioxamine; BPS, bathophenanthroline disulfonate; FLC, fluconazole; VRC, voriconazole; and FEN, fenpropimorph. (b) Effects of ergosterol supplementation on azole susceptibility of the C. glabrata DAP1 mutants. The spot dilution assay was performed as in part (a) except that C. glabrata cells were grown under low oxygen tension to facilitate ergosterol uptake. Plates were incubated at 30°C for 3 days.
performed sterol assays using reverse-phase HPLC. Compared with the wild-type and DAP1-complemented strains, the Ddap1 and DAP1 D91G mutants exhibited slightly reduced amounts of ergosterol and more than twofold higher accumulation of lanosterol and squalene (Fig. 4) , which are 14a-methylated sterol intermediates produced upstream of Erg11 in the ergosterol biosynthetic pathway (Onyewu et al., 2003; Martel et al., 2010; Hull et al., 2012) (Fig. 5) ; this indicates a partial defect of Erg11 activity in the mutants. In S. cerevisiae, Dap1 does not affect ERG11 transcription but regulates the stability of the Erg11 protein (Mallory et al., 2005) . Our qRT-PCR assay also revealed that the expression level of ERG11 in the Ddap1 mutant was comparable to that in the wild-type strain in C. glabrata (data not shown). Intriguingly, the overexpression of ERG11 resulted in increased azole tolerance in the wild-type background, while this effect was modest in the Ddap1 background in C. glabrata (Fig. 6) , in contrast to previous findings in S. cerevisiae where ERG11 overexpression confers itraconazole resistance in both wildtype and Ddap1 backgrounds (Mallory et al., 2005) . Taken together, these results suggest that Dap1 acts on Erg11 post-transcriptionally depending on its heme-binding activity but may have an additional role in azole resistance Fig. 4 . Sterol analysis. Candida glabrata cells were grown under normal growth conditions using SD medium. Sterol contents were analyzed by reverse-phase HPLC, as described in Materials and Methods. The data shown are the results of a single experiment that was repeated on two independent occasions with similar results. C. glabrata strains: Wild-type control, TG12; Ddap1 + vector, TG252; Ddap1 + DAP1, TG253; and Ddap1 + DAP1 D91G , TG254. A linear model of the pathway was adapted from references (Onyewu et al., 2003; Martel et al., 2010; Hull et al., 2012) , and only selected intermediates and enzymes are shown. Solid and broken arrows indicate single and multiple enzymatic steps, respectively. The known targets of fluconazole, voriconazole, and fenpropimorph are indicated. in C. glabrata. It is worth mentioning that the changes in sterol compositions in the C. glabrata Ddap1 mutant were similar to those previously observed in S. cerevisiae wildtype cells grown under low-iron conditions (ShakouryElizeh et al., 2010) . In addition, another P450 enzyme, C-22 sterol desaturase (Erg5p), acts downstream of Erg11 in the ergosterol biosynthesis pathway (Lamb et al., 1999) . A previous study in S. cerevisiae has suggested that Erg5 is not a target for Dap1 in methyl methanesulfonate resistance, but the Erg5p substrate ergosta-5,7-dienol accumulated in a Ddap1 mutant under normal growth conditions (Mallory et al., 2005) . Future studies are needed to determine whether Erg5 is a target for Dap1 in azole resistance in S. cerevisiae and C. glabrata.
Dap1 plays a role in the regulation of vacuole structures
We next investigated intracellular localization of Dap1 using a Dap1-GFP fusion protein in C. glabrata. The Ddap1 phenotypes were complemented by the introduction of DAP1-EGFP1 into the mutant (Fig. 3a) , indicating that this fusion protein is biologically functional. Dap1-GFP predominantly localized to FM4-64-stained vacuole membranes and endosomes in C. glabrata (Fig. 7a) . In S. cerevisiae, Dap1 localizes mainly to endosomes (Craven et al., 2007) , while Erg11 localizes to the ER (Huh et al., 2003) , cytoplasm (Natter et al., 2005) , and granular sites (Wiwatwattana et al., 2007) . Although Dap1 may participate in intracellular heme trafficking to activate the P450 hemoprotein Erg11, a stable physical interaction between Dap1 and Erg11 has not been detected in S. cerevisiae (Craven et al., 2007) . These results suggest that interaction between Dap1 and Erg11 may be transient or indirect in S. cerevisiae and C. glabrata. The vast majority of vacuoles were stained with FM4-64 as circular structures in the C. glabrata wild-type cells, whereas a significant fraction of vacuoles displayed abnormal structures, such as multiple small constructions with irregular edges, in the Ddap1 mutant (Fig. 7b and c) . It is likely that vacuolar iron storage is impaired in cells with aberrant vacuole structures (Raguzzi et al., 1988; Craven et al., 2007) ; thus, the results may, at least in part, account for the decreased tolerance of the Ddap1 mutant to iron starvation.
Concluding remarks
To our knowledge, this is the first report in pathogenic fungi, characterizing Dap1 as a molecule linking iron homeostasis and azole resistance. Dap1 interacted genetically with Erg11, thereby indirectly participating in ergosterol biosynthesis in C. glabrata. Iron depletion or dysfunction of Dap1 impairs Erg11 activity, leading to increased azole susceptibility in C. glabrata. Previous studies in pathogenic fungi, such as C. albicans, A. fumigatus, C. neoformans, and Rhizopus oryzae, suggest the potential use of iron chelators in antifungal therapy (Ibrahim et al., 2006 (Ibrahim et al., , 2007 Prasad et al., 2006; Zarember et al., 2009; Fiori & Van Dijck, 2012; Kim et al., 2012) , although the adverse effects of this therapy on mammalian cells remain an issue. Our results suggest that inhibition of Dap1 could be an alternative approach. As Dap1 is highly conserved at the sequence level from yeast to filamentous fungi, but not in humans, further studies on Dap1 orthologs in other pathogenic fungi are warranted in the quest for novel antifungal strategies.
